MusclePharm, which makes branded sports nutrition products and energy beverages, filed on Friday with the SEC to raise up to $10 million in an initial public offering. The company is currently listed on the OTC (MSLP) with a market cap of approximately $6 million.
If the company's market cap is less than $50 million at the time of its pricing and uplisting, MusclePharm will be excluded from Renaissance Capital's 2022 IPO stats.
MusclePharm develops, manufactures, markets, and distributes branded sports nutrition products and functional energy beverages. The company's portfolio consists of six products under the brands MusclePharm and FitMiss, which are sold in more than 100 countries globally through its specialty, international, FDM, and newly introduced grocery and convenience distribution channels.
The Las Vegas, NV-based company was founded in 2006 and booked $50 million in sales for the 12 months ended March 31, 2022. It plans to list on the Nasdaq under the symbol MSLP. Roth Capital is the sole bookrunner on the deal. No pricing terms were disclosed.
